Ali Talebi

3.4k total citations · 2 hit papers
16 papers, 1.8k citations indexed

About

Ali Talebi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ali Talebi has authored 16 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ali Talebi's work include Cancer, Lipids, and Metabolism (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and RNA modifications and cancer (4 papers). Ali Talebi is often cited by papers focused on Cancer, Lipids, and Metabolism (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and RNA modifications and cancer (4 papers). Ali Talebi collaborates with scholars based in Belgium, Canada and France. Ali Talebi's co-authors include Johannes V. Swinnen, Jonas Dehairs, Sarah‐Maria Fendt, Lindsay A. Broadfield, Samira Aghayee, Elham Ghaderi, Omid Akhavan, Vincent de Laat, William B. Kinlaw and Massimo Loda and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ali Talebi

16 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipid metabolism in cancer: New perspectives and emerging mechanisms

2021 426 citations Lindsay A. Broadfield, Ali Talebi et al. Developmental Cell profile →
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

2020 408 citations Lisa M. Butler, Ylenia Perone et al. Advanced Drug Delivery Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ali Talebi Belgium	9	961	758	328	289	250	16	1.8k
Ganfeng Xie China	22	849 0.9×	576 0.8×	277 0.8×	209 0.7×	191 0.8×	44	1.6k
Yue Wu China	29	1.0k 1.1×	428 0.6×	458 1.4×	140 0.5×	390 1.6×	110	2.3k
Zhi‐Ren Liu United States	25	1.2k 1.2×	585 0.8×	113 0.3×	228 0.8×	144 0.6×	58	2.2k
Bing Song China	26	1.5k 1.5×	986 1.3×	326 1.0×	135 0.5×	349 1.4×	68	2.8k
Brenda Baggett United States	16	1.2k 1.2×	903 1.2×	390 1.2×	152 0.5×	113 0.5×	21	2.1k
Dongqin Yang China	26	1.0k 1.1×	310 0.4×	607 1.9×	618 2.1×	168 0.7×	84	2.3k
Sung-Gil Chi South Korea	29	1.9k 2.0×	574 0.8×	384 1.2×	285 1.0×	308 1.2×	72	2.9k
Pierre Danhier Belgium	21	1.2k 1.3×	999 1.3×	563 1.7×	144 0.5×	185 0.7×	39	2.4k
Shourong Wu China	26	1.4k 1.4×	510 0.7×	353 1.1×	123 0.4×	236 0.9×	65	2.2k
Pingfu Hou China	28	1.8k 1.8×	1.0k 1.3×	165 0.5×	187 0.6×	196 0.8×	60	2.4k

Countries citing papers authored by Ali Talebi

Since Specialization

Citations

This map shows the geographic impact of Ali Talebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Talebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Talebi more than expected).

Fields of papers citing papers by Ali Talebi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Talebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Talebi. The network helps show where Ali Talebi may publish in the future.

Co-authorship network of co-authors of Ali Talebi

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Talebi. A scholar is included among the top collaborators of Ali Talebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Talebi. Ali Talebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Laat, Vincent de, Xander Spotbeen, Ali Talebi, et al.. (2024). Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nature Communications. 15(1). 8540–8540. 6 indexed citations

Zeeuw, Pauline de, Lucas Treps, Melissa García‐Caballero, et al.. (2024). The gluconeogenesis enzyme PCK2 has a non-enzymatic role in proteostasis in endothelial cells. Communications Biology. 7(1). 618–618. 2 indexed citations

Huang, Fan, Michael S. Dahabieh, Ali Talebi, et al.. (2023). Peroxisome disruption alters lipid metabolism and potentiates antitumor response with MAPK-targeted therapy in melanoma. Journal of Clinical Investigation. 133(20). 18 indexed citations

Kiss, Máté, Aleksandar Murgaski, Helena Van Damme, et al.. (2022). Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment. Frontiers in Immunology. 13. 1003975–1003975. 4 indexed citations

Planque, Mélanie, Esther A. Zaal, Lara Rizzotto, et al.. (2022). 2022-RA-953-ESGO Serine metabolism remodeling after platinum-based chemotherapy is a new vulnerability in resistant ovarian cancer patients. A285–A285. 1 indexed citations

Broadfield, Lindsay A., et al.. (2021). Lipid metabolism in cancer: New perspectives and emerging mechanisms. Developmental Cell. 56(10). 1363–1393. 426 indexed citations breakdown →

Butler, Lisa M., Ylenia Perone, Jonas Dehairs, et al.. (2020). Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. Advanced Drug Delivery Reviews. 159. 245–293. 408 indexed citations breakdown →

Rockstroh, Anja, Berwyck L. J. Poad, Ali Talebi, et al.. (2020). Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer. SHILAP Revista de lepidopterología. 8(1). 11–11. 76 indexed citations

Li, Yue, Shuncong Wang, Yuanyu Zhao, et al.. (2020). A Model In Vitro Study Using Hypericin: Tumor-Versus Necrosis-Targeting Property and Possible Mechanisms. Biology. 9(1). 13–13. 7 indexed citations

10.

Dehairs, Jonas, et al.. (2019). A New Classification Method of Metastatic Cancers Using a 1H-NMR-Based Approach: A Study Case of Melanoma, Breast, and Prostate Cancer Cell Lines. Metabolites. 9(11). 281–281. 6 indexed citations

11.

Talebi, Ali, Jonas Dehairs, Florian Rambow, et al.. (2018). Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. Nature Communications. 9(1). 2500–2500. 105 indexed citations

12.

Cai, Yanyan, Tibor J. Pastor, Layka Abbasi Asbagh, et al.. (2016). Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism. Cancer Cell. 29(5). 751–766. 126 indexed citations

13.

Dehairs, Jonas, Ali Talebi, Yacine Chérifi, & Johannes V. Swinnen. (2016). CRISP-ID: decoding CRISPR mediated indels by Sanger sequencing. Scientific Reports. 6(1). 28973–28973. 165 indexed citations

14.

Khan, Niamat, Ali Talebi, Arnaud Marchand, et al.. (2016). Identification of drugs that restore primary cilium expression in cancer cells. Oncotarget. 7(9). 9975–9992. 61 indexed citations

15.

Talebi, Ali, Jonas Dehairs, & Johannes V. Swinnen. (2012). De novo lipogenesis and membrane remodeling in cancer.. 23. 49–53. 3 indexed citations

16.

Akhavan, Omid, et al.. (2012). The use of a glucose-reduced graphene oxide suspension for photothermal cancer therapy. Journal of Materials Chemistry. 22(27). 13773–13773. 385 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact